Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$912,234,002
+$100,516,959 QoQ
Shares Held
3,625,155
-2.9% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#54
of 4,138 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. ABBV ranks #4 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $912,234,002 | 3,625,155 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $811,717,043 | 3,732,204 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $563,843,856 | 2,467,696 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $572,633,611 | 2,473,152 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $464,132,784 | 2,500,446 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $502,488,879 | 2,398,286 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $458,329,169 | 2,579,230 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $494,028,999 | 2,501,666 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $433,894,483 | 2,529,702 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $447,231,952 | 2,455,969 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $358,438,169 | 2,312,952 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $350,204,541 | 2,349,420 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $317,571,677 | 2,357,097 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $412,665,980 | 2,589,358 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $458,653,864 | 2,838,029 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $377,925,828 | 2,815,929 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $418,506,938 | 2,732,482 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $452,261,444 | 2,789,843 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $378,417,000 | 2,794,808 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $291,543,050 | 2,702,726 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $294,550,667 | 2,614,974 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $275,218,824 | 2,543,142 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $240,177,151 | 2,241,504 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $195,382,892 | 2,230,653 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $215,048,953 | 2,190,354 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $156,739,512 | 2,057,219 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||